Phase 4 Study - Mucinex D as Adjunct Therapy

Status Completed

Clinical Trial Summary

The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00441246
Study type	Interventional
Source	Adams Respiratory Therapeutics
Contact
Status	Completed
Phase	Phase 4
Start date	February 2007
Completion date	July 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03943654` - Improving Nighttime Access to Care and Treatment (Part 2)
Completed	`NCT05269290` - Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections	Phase 3
Completed	`NCT06385821` - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus	Phase 3
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Not yet recruiting	`NCT04525118` - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
Completed	`NCT01431469` - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil	N/A
Completed	`NCT00981513` - Direct and Indirect Benefits of Influenza Vaccination in Schools and Households	Phase 4
Recruiting	`NCT06183229` - Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza	Phase 3
Completed	`NCT03274310` - FluSAFE: Flu SMS Alerts to Freeze Exposure	N/A
Completed	`NCT03736096` - Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Completed	`NCT03028077` - Effects of GS-3K8 and GINst15 on Acute Respiratory Illness	N/A
Enrolling by invitation	`NCT01286285` - Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria	N/A
Completed	`NCT03840135` - Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI	Phase 3
Completed	`NCT01488435` - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age	N/A
Not yet recruiting	`NCT00545961` - Middle Meatal Bacteriology During Acute Respiratory Infection in Children	Phase 4
Completed	`NCT05273619` - Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection	Phase 3
Recruiting	`NCT04415827` - Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases	N/A
Completed	`NCT03459391` - Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers	Phase 1
Withdrawn	`NCT04938323` - Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly	Phase 2/Phase 3